Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast Cancer

BACKGROUND: Tamoxifen (TAM) and Toremifene (TOR), two kinds of selective estrogen receptor modulators (SERMs), have equal efficacy in breast cancer patients. However, TAM has been proved to affect serum lipid profiles and cause fatty liver disease. The study aimed to compare the effects of TAM and T...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Dandan, Hu, Yingying, Diao, Biyu, Miao, Rongrong, Zhang, Baodan, Cai, Yangjun, Zeng, Hanqian, Zhang, Yuru, Hu, Xiaoqu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272257/
https://www.ncbi.nlm.nih.gov/pubmed/34246237
http://dx.doi.org/10.1186/s12885-021-08538-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272257/
https://www.ncbi.nlm.nih.gov/pubmed/34246237
http://dx.doi.org/10.1186/s12885-021-08538-5

Ejemplares similares